Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.
Aclaris' stock has dropped nearly 70% since September 2023, reflecting its history of failures and dissipations. Explore more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback